INVIVO THERAPEUTICS
InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.
INVIVO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.invivotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+116178635535
Email Addresses:
[email protected]
Total Funding:
116.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arch Therapeutics
Arch Therapeutics is a medical device company offering an innovative therapeutic approach to stasis and barrier applications.
Asthmatx
Asthmatx is a medical device company focused on developing and commercializing a therapeutic treatment for asthma in the United States.
Avanir Pharmaceuticals
Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
BAROnova
BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
Biosency
BIOSENCY is a medical device company focused on developing smart healthcare solutions.
Brainsgate
BrainsGate is a medical device company developing innovative therapies for patients suffering from central nervous system diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
ConverGene
ConverGene is a small molecule discovery company leveraging rational drug design.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Denali Medical
Denali Medical II is a medical device incubator focused on creating new therapies for unmet and/or underserved clinical needs.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Dynocardia
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
MedNews
MedNews is a medical device company developing treatments for patients with heart failure.
MELA Sciences
MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide
Micell Technologies
Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Mirabilis Medical
Mirabilis Medical is a medical device company that focuses on the treatment of uterine fibroids that is a common problem for women.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Osseon Therapeutics
Osseon Therapeutics develops medical devices for minimally-invasive treatments of degenerative bone and joint diseases.
Paragonix Technologies
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Pearltec AG
Pearltec is a technology company focused on placement, positioning, and fixation solutions for patients in research imaging studies.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Precision Light
Precision Light is operates as a medical device company focused on developing breast, facial.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Q30 Innovations
Q30 Innovations is a research and development company dedicated to developing innovative products intended to reduce traumatic brain injury.
Recros Medica
Recros Medica is a medical device company developing technologies to treat skin laxity and focal aesthetic contour deformities.
Refocus Group
Refocus Group is a medical device company engaged in the research and development of treatments for human vision disorders.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Synergy Biomedical
Synergy Biomedical is a medical device company that focuses on bringing innovative biomaterial-based products to the orthopedic market.
Thermogenesis
Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - InVivo Therapeutics
SternAegis
SternAegis investment in Post-IPO Equity - InVivo Therapeutics
Montrose Capital Partners
Montrose Capital Partners investment in Post-IPO Equity - InVivo Therapeutics
Spencer Trask & Co
Spencer Trask & Co investment in Post-IPO Equity - InVivo Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-07-13 | InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel |
Official Site Inspections
http://www.invivotherapeutics.com Semrush global rank: 9.96 M Semrush visits lastest month: 73
- Host name: 137.54.154.104.bc.googleusercontent.com
- IP address: 104.154.54.137
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "InVivo Therapeutics" on Search Engine
About Us – InVivo Therapeutics
By modulating the healing environment to facilitate cell survival and growth, we have the opportunity to change the treatment of spinal cord injury. We have steadily advanced our scaffold technology through years of research and …See details»
InVivo Therapeutics – Redefining the treatment of spinal cord injury
Learn how our technology is designed to support cell survival and growthSee details»
InVivo Therapeutics - Crunchbase Company Profile & Funding
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries. Cambridge, Massachusetts, United States. 1-10. Post-IPO Equity. Public. www.invivotherapeutics.com. 42,573. Stock Symbol NASDAQ:NVIV. Total Funding Amount. Unlock for free. Contacts 10. Employee Profiles 7.See details»
InVivo Therapeutics | LinkedIn
InVivo Therapeutics | 2,400 followers on LinkedIn. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company...See details»
InVivo Therapeutics Announces 75% Target Enrollment Achieved …
Sep 8, 2021 About InVivo Therapeutics. InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.See details»
Investor Relations | Invivo Therapeutics
Oct 7, 2022 Corporate Profile. InVivo Therapeutics (Nasdaq: NVIV) is a clinical-stage biotechnology company focused on redefining the treatment of spinal cord injury. InVivo’s proprietary and investigational Neuro-Spinal Scaffold, based on technology licensed from Robert S. Langer’s lab at Massachusetts Institute of Technology, is in pivotal clinical ...See details»
Our Pipeline – InVivo Therapeutics
Our pipeline. Our Neuro-Spinal Scaffold™ has the potential to provide meaningful benefit in acute thoracic spinal cord injury patients, either alone or in combination with other technologies. Our INSPIRE 2.0 clinical study.See details»
Rapid intervention—pioneering technology: redefining spinal cord …
Produced by. InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries (SCIs). InVivo’s...See details»
InVivo Therapeutics Announces Topline Data from Pivotal …
Mar 9, 2023 InVivo Therapeutics is a clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology...See details»
SEC Filing | Invivo Therapeutics
InVivo Therapeutics Holdings Corp., including its subsidiary (the “Company”) is a biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (“SCIs”).See details»
InVivo Therapeutics - Funding, Financials, Valuation & Investors
InVivo Therapeutics has raised a total of. $125.2M. in funding over 9 rounds. Their latest funding was raised on Oct 7, 2022 from a Post-IPO Equity round. InVivo Therapeutics is registered under the ticker NASDAQ:NVIV . InVivo Therapeutics is funded by 4 investors.See details»
202 Annual Report
INVIVO THERAPEUTICS HOLDINGS CORP. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 36-4528166 (I.R.S. Employer Identification No.) One Kendall Square, Building 1400 West, 4th Floor, Suite B14402, Cambridge, Massachusetts (Address of principal executive offices) 02139See details»
Bob Langer-founded InVivo Therapeutics declares bankruptcy
Feb 6, 2024 Health Care. Bob Langer-founded device-maker declares bankruptcy. Unlock URL. |. Richard Toselli is the most recent CEO of InVivo Therapeutics. Courtesy photo. By Hannah Green – Reporter,...See details»
Our Technology – InVivo Therapeutics
Our proprietary and investigational Neuro-Spinal Scaffold technology is composed of two biocompatible and bioresorbable polymers which together form a highly porous framework that is conducive to cellular attachment and growth.See details»
InVivo Therapeutics | CipherBio
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. The company was founded in 2005 with proprietary technology co-invented by Robert Langer, Sc ... Stage: Public. Total Funds Raised: $0.00. Funding Products Partners People News Network.See details»
InVivo Therapeutics - Contacts, Employees, Board Members, …
InVivo Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 7. Number of Board Member and Advisor Profiles 5. Contacts 10. About. InVivo Therapeutics has 7 current employee profiles, including Chief Financial Officer Richard Christopher.See details»
Therapeutic Alliance, LLC | Behavioral and Mental Health Care …
Therapeutic Alliance is a private mental health agency offering comprehensive, individualized behavioral, and mental health care services in Virginia.See details»
HOME | Neatly Ever After
At Neatly Ever After, we are committed to creating custom organizational systems that target the challenging areas of your home. We leave you with organizational solutions that last and are easily maintained by the whole family. Your customized solution can serve you in any part of your life - from your home, to your business, and even your ...See details»
InVivo Therapeutics - Tech Stack, Apps, Patents & Trademarks
Apr 26, 2024 About. InVivo Therapeutics uses 19 technology products and services including HTML5 , jQuery , and Google Analytics, according to G2 Stack. InVivo Therapeutics is actively using 5 technologies for its website, according to BuiltWith. These include Domain Not Resolving , IPv6 , and Microsoft. Company Tech Stack by G2 …See details»
2021 Annual Report - Invivo Therapeutics
INVIVO THERAPEUTICS HOLDINGS CORP. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 36-4528166 (I.R.S. Employer Identification No.) One Kendall Square, Building 1400 West, 4th Floor, Suite B14402, Cambridge, Massachusetts (Address of principal executive offices) 02139See details»